Genomics, health and development

November 2004
Outlook on Science Policy;Nov2004, Vol. 26 Issue 10, p119
The article reports that a report of the Genomics Working Group of the Science Technology and Innovation Task Force of the United Nations Millennium Project has been released by the team from the University of Toronto Joint Centre for Bioethics. The genomics revolution, according to the authors, holds the potential to improve health in developing countries and, if harnessed appropriately, could help to reduce the development divide between North and South. Learning is key to building a genomics capacity, and the authors suggest the need for a national innovation system in biotechnology in developing countries.


Related Articles

  • R&D UPDATE - Genomics.  // PharmaWatch: Biotechnology;March 2003, Vol. 2 Issue 3, p7 

    Cites news events related to the genomics sector in the corporate and academic areas of the biotechnology industry. Validation agreement between Isis Pharmaceutical and Pfizer; Discovery of a depression gene by Myriad Genetics; Breakthrough by the Saint Louis University in its study of the cause...

  • "Like playing chess with no squares". Dietderich, Andrew // Crain's Detroit Business;6/5/2006, Vol. 22 Issue 23, p13 

    The article analyzes the potential of Michigan to become a biotech powerhouse. It is not an easy task for a state built on automotive and manufacturing capabilities to become a biotech powerhouse. When California-based think tank Milken Institute studied the major areas of biotech and life...

  • Convention breaks down over protecting gene pool. Sattaur, Omar // New Scientist;12/15/90, Vol. 128 Issue 1747, p12 

    Reports that a dispute over who should control biotechnology threatens to disrupt a global convention to conserve biological diversity. How developing countries demand access to expertise in biotechnology; Consideration of how aid agreements to provide for technology transfer according to one...

  • Come hither, biotech. Wirtz, Ronald A. // Fedgazette;Sep2003, Vol. 15 Issue 5, p5 

    Discusses the significance of biotechnology to states and universities in the U.S. Involvement of a college student in biotechnology development; Application of biotechnology in the pharmaceutical industry; Methods to facilitate growth of biotechnology. INSET: Biotech by any other measure.

  • Genomics: catch me if you can. Blow, Nathan // Nature Methods;Jul2009, Vol. 6 Issue 7, p539 

    The article presents information on the emergence of new technologies in sequencing of genomes. It states that the next-generation sequencing has made decoding entire genomes cheaper and faster. However, it highlights that researchers interested in using the technology to investigate specific...

  • Children's Blocks, Libraries Help Students Unravel Genomics.  // Ascribe Newswire: Medicine;9/29/2005, p14 

    The article reports on an educational model developed by Purdue University researchers which focuses on the use of simple children's plastic building blocks and other familiar objects for teaching high school and college students the intricacies of biotechnology and genomics. The program is...

  • New growth-stimulating cue identified for nerve cells.  // PharmaWatch: Biotechnology;September 2003, Vol. 2 Issue 9, p29 

    Reports that researchers at Johns Hopkins University have found that within a family of proteins best known for repelling axons and inhibiting their growth, one member exist that actually promotes axon growth. Observation on growth of rat nerves; Leading researchers of the study; Significance of...

  • Computational Optimization of Genes.  // Drug Discovery & Development;Jun2005, Vol. 8 Issue 6, p22 

    The article reports that CODA Genomics Inc., a spin-off company of the University of California will offer a new technology developed for Computer Optimized DNA Assembly (CODA) and protein expression optimization. The technology was developed at the university's Institute for Genomics and...

  • The Observatory. Genetics/Genomics.  // MLO: Medical Laboratory Observer;Feb2015, Vol. 47 Issue 2, p6 

    The article reports on a collaboration between biotechnology firm Biogen Idec and Columbia University Medical Center to conduct genetics discovery research on the causes of disease backed by the drug development expertise of Biogen and the genomics expertise of Columbia.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics